Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$37.68−1.49 (-3.80%)
Close on Nov 17, 2026Market cap $49.54BP/E –Yield –
Medline operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Medline's operating cash flow for the twelve months ending Sep 26, 2026 was $2.38B. For fiscal 2025 it was $1.74B, down 1.4% from the year before.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | -1.4% |
| FY2024 | Dec 31, 2024 | $1.77B | +5.0% |
| FY2023 | Dec 31, 2023 | $1.69B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $1.03B | +61.2% |
| Q2 FY2026 | Jun 27, 2026 | $715.00M | +262.9% |
| Q1 FY2026 | Mar 28, 2026 | $412.00M | -39.6% |
| Q4 FY2025 | Dec 31, 2025 | $229.00M | – |
| Q3 FY2025 | Sep 27, 2025 | $636.00M | – |
| Q2 FY2025 | Jun 28, 2025 | $197.00M | – |
| Q1 FY2025 | Mar 29, 2025 | $682.00M | – |
See a number that looks wrong?